NYSE$UNH

UnitedHealth · Q4 2019 earnings

Q4 2019 earnings · · Investor relations

Briefing

UnitedHealth Group reported strong Q4 2019 results driven by diversified performance across its businesses.

UnitedHealth Group reported full year revenues of $242 billion, a growth of $16 billion or 7% year-over-year. The company's full year and fourth quarter net earnings per share were $14.33 and $3.68, growing 18% and 19% year-over-year, respectively. Full year and fourth quarter adjusted net earnings per share were $15.11 and $3.90, reflecting growth of 17% and 19% year-over-year. The company also reported full year cash flows from operations of $18.5 billion.

  • Full year revenues reached $242 billion, growing by $16 billion or 7% year-over-year.
  • Full year and Q4 net earnings per share grew by 18% and 19% year-over-year, respectively.
  • Full year and Q4 adjusted net earnings per share increased by 17% and 19% year-over-year, respectively.
  • Full year cash flows from operations amounted to $18.5 billion, demonstrating a 17.5% year-over-year growth.

Headline financials

Total Revenue

$60.9B

Previous: $58.4B+4.3%
EPS (adj)

$3.90

Previous: $3.28+18.9%
Capital Expenditures

$650M

Previous: $558M+16.5%
Free Cash Flow

$5.56B

Previous: $1.84B+202.2%
Net Income

$3.67B

Previous: $3.04B+20.7%
Operating Income

$5.1B

Previous: $4.5B+13.3%
Gross Profit

$15.1B

Previous: $13.8B+9.2%
Stock-Based Comp

$172M

Previous: $126M+36.5%

Revenue & EPS history

UnitedHealth · Revenue · Quarterly

$60.9B

Q4 2019+4.3%vs Q4 2018
Beat estimate in 16 of 16 quarters(100%)
ActualEstimate

Revenue by segment

UnitedHealth · $92.4B total across 4 segments · Q3 2023

  • Premiums
    $72.3B+12.2%
  • Products
    $10.4B+12.7%
  • Services
    $8.67B+29.4%
  • Investment & Other
    $997M+94.3%

Forward guidance

The Company affirmed its recently issued full year earnings outlook for 2020, including net earnings of $15.45 to $15.75 per share and adjusted net earnings of $16.25 to $16.55 per share.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2019

Historical avgQ4 2019

+0.9%

Avg return

Earnings day

+1.3%

Avg return

5 days after

+2.6%

Avg return

30 days after

63%

46 / 73 earnings

Positive

+11.2%

Q2 2024

Best reaction

-22.4%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+9.7%+18.1%
Q4 2025-11.2%-18.4%-18.5%
Q3 2025+0.1%-6.7%-9.9%
Q2 2025+0.6%+21.2%+38.2%
Q1 2025-22.4%-27.0%-50.1%
Q4 2024-6.2%-3.4%-3.7%
Q3 2024-5.6%-5.9%-2.0%
Q2 2024+11.2%+9.7%+12.5%
Q1 2024+7.5%+12.5%+17.0%
Q4 2023-3.8%-2.7%-4.0%
Q3 2023+2.4%+2.0%+3.0%
Q2 2023+8.1%+12.5%+13.5%
Q1 2023-4.0%-7.6%-6.7%
Q4 2022-2.1%-3.9%-0.3%
Q3 2022+2.3%+2.0%+2.4%
Q2 2022+3.4%+3.4%+8.2%
Q1 2022-0.5%+0.1%-9.6%
Q4 2021+0.4%+0.3%+1.5%
Q3 2021+6.1%+5.2%+13.7%
Q2 2021+1.2%-0.4%-1.2%
Q1 2021+4.1%+5.6%+9.1%
Q4 2020+0.8%-1.2%-7.8%
Q3 2020-2.1%-2.2%+7.3%
Q2 2020-0.4%-1.6%+4.9%
Q1 2020+10.3%+4.3%+7.6%
Q4 2019+4.3%+3.5%+3.7%
Q3 2019+7.4%+11.2%+16.0%
Q2 2019-3.8%-4.4%-7.9%
Q1 2019-5.8%-3.7%+2.9%
Q4 2018+5.4%+7.0%+7.0%
Q3 2018+2.7%+1.9%+1.8%
Q2 2018-0.6%-1.7%+2.4%
Q1 2018+2.6%+2.1%+5.5%
Q4 2017+4.3%+6.4%-1.1%
Q3 2017+6.2%+7.4%+9.3%
Q2 2017+1.5%+2.9%+3.4%
Q1 2017+1.2%+2.4%+2.6%
Q4 2016-2.5%-1.9%+1.1%
Q3 2016+7.6%+8.4%+12.4%
Q2 2016+1.6%+2.1%+1.0%
Q1 2016+4.8%
Q4 2015+5.1%
Q3 2015-1.7%
Q2 2015-1.6%
Q1 2015+1.2%
Q4 2014+7.8%
Q3 2014+7.3%
Q2 2014+2.1%
Q1 2014-4.1%
Q4 2013-3.1%
Q3 2013-8.6%
Q2 2013+7.9%
Q1 2013-3.2%
Q4 2012+1.7%
Q3 2012-2.6%
Q2 2012-1.7%
Q1 2012+3.8%
Q4 2011+2.3%
Q3 2011-2.2%
Q2 2011-1.7%
Q1 2011+0.5%
Q4 2010+0.7%
Q3 2010-0.5%
Q2 2010+1.6%
Q1 2009-0.8%
Q1 2010-0.2%
Q4 2009+0.4%
Q4 2007+0.4%
Q3 2008+5.5%
Q3 2009+5.5%
Q4 2008+1.3%
Q2 2008+1.3%
Q2 2009+1.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro